Annual Retained Earnings
-$1.35 B
+$21.59 M+1.58%
December 31, 2023
Summary
- As of February 7, 2025, PBYI annual retained earnings is -$1.35 billion, with the most recent change of +$21.59 million (+1.58%) on December 31, 2023.
- During the last 3 years, PBYI annual retained earnings has fallen by -$7.53 million (-0.56%).
- PBYI annual retained earnings is now -4606626.03% below its all-time high of -$29.20 thousand, reached on December 31, 2008.
Performance
PBYI Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$1.33 B
+$20.32 M+1.50%
September 30, 2024
Summary
- As of February 7, 2025, PBYI quarterly retained earnings is -$1.33 billion, with the most recent change of +$20.32 million (+1.50%) on September 30, 2024.
- Over the past year, PBYI quarterly retained earnings has increased by +$23.24 million (+1.71%).
- PBYI quarterly retained earnings is now -4569047.26% below its all-time high of -$29.20 thousand, reached on December 31, 2008.
Performance
PBYI Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
PBYI Retained Earnings Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +1.6% | +1.7% |
3 y3 years | -0.6% | +1.9% |
5 y5 years | -11.9% | +1.9% |
PBYI Retained Earnings Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +1.6% | at high | +2.6% |
5 y | 5-year | -5.3% | +1.6% | -4.4% | +2.7% |
alltime | all time | <-9999.0% | +1.6% | <-9999.0% | +2.7% |
Puma Biotechnology Retained Earnings History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | -$1.33 B(-1.5%) |
Jun 2024 | - | -$1.35 B(+0.3%) |
Mar 2024 | - | -$1.35 B(+0.4%) |
Dec 2023 | -$1.35 B(-1.6%) | -$1.35 B(-0.9%) |
Sep 2023 | - | -$1.36 B(-0.4%) |
Jun 2023 | - | -$1.36 B(-0.2%) |
Mar 2023 | - | -$1.37 B(-0.1%) |
Dec 2022 | -$1.37 B(-0.0%) | -$1.37 B(+0.4%) |
Sep 2022 | - | -$1.36 B(+0.0%) |
Jun 2022 | - | -$1.36 B(-0.7%) |
Mar 2022 | - | -$1.37 B(+0.2%) |
Dec 2021 | -$1.37 B(+2.2%) | -$1.37 B(-0.3%) |
Sep 2021 | - | -$1.37 B(+3.4%) |
Jun 2021 | - | -$1.33 B(+0.4%) |
Mar 2021 | - | -$1.32 B(-1.2%) |
Dec 2020 | -$1.34 B(+4.7%) | -$1.34 B(+1.1%) |
Sep 2020 | - | -$1.32 B(+2.4%) |
Jun 2020 | - | -$1.29 B(-0.3%) |
Mar 2020 | - | -$1.29 B(+1.3%) |
Dec 2019 | -$1.28 B(+6.3%) | -$1.28 B(+0.9%) |
Sep 2019 | - | -$1.27 B(+1.4%) |
Jun 2019 | - | -$1.25 B(+3.1%) |
Mar 2019 | - | -$1.21 B(+0.8%) |
Dec 2018 | -$1.20 B(+10.4%) | -$1.20 B(+2.6%) |
Sep 2018 | - | -$1.17 B(+1.2%) |
Jun 2018 | - | -$1.16 B(+4.0%) |
Mar 2018 | - | -$1.11 B(+2.2%) |
Dec 2017 | -$1.09 B(+36.7%) | -$1.09 B(+6.3%) |
Sep 2017 | - | -$1.02 B(+8.1%) |
Jun 2017 | - | -$947.21 M(+9.0%) |
Mar 2017 | - | -$869.38 M(+9.1%) |
Dec 2016 | -$796.51 M | -$796.51 M(+10.0%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2016 | - | -$723.85 M(+10.0%) |
Jun 2016 | - | -$658.07 M(+11.3%) |
Mar 2016 | - | -$591.47 M(+13.6%) |
Dec 2015 | -$520.50 M(+85.1%) | -$520.50 M(+13.5%) |
Sep 2015 | - | -$458.78 M(+15.2%) |
Jun 2015 | - | -$398.36 M(+19.4%) |
Mar 2015 | - | -$333.67 M(+18.7%) |
Dec 2014 | -$281.22 M(+101.9%) | -$281.22 M(+20.3%) |
Sep 2014 | - | -$233.73 M(+18.1%) |
Jun 2014 | - | -$197.89 M(+24.4%) |
Mar 2014 | - | -$159.04 M(+14.2%) |
Dec 2013 | -$139.25 M(+64.6%) | -$139.25 M(+12.9%) |
Sep 2013 | - | -$123.31 M(+13.1%) |
Jun 2013 | - | -$109.02 M(+13.1%) |
Mar 2013 | - | -$96.37 M(+13.9%) |
Dec 2012 | -$84.59 M(+726.1%) | -$84.59 M(+35.0%) |
Sep 2012 | - | -$62.68 M(+70.2%) |
Jun 2012 | - | -$36.82 M(+66.9%) |
Mar 2012 | - | -$22.07 M(+115.5%) |
Dec 2011 | -$10.24 M(>+9900.0%) | -$10.24 M(>+9900.0%) |
Sep 2011 | - | -$77.10 K(+6.8%) |
Jun 2011 | - | -$72.20 K(+4.8%) |
Mar 2011 | - | -$68.90 K(+11.1%) |
Dec 2010 | -$62.00 K(+34.8%) | -$62.00 K(+10.1%) |
Sep 2010 | - | -$56.30 K(+6.0%) |
Jun 2010 | - | -$53.10 K(+4.7%) |
Mar 2010 | - | -$50.70 K(+10.2%) |
Dec 2009 | -$46.00 K(+57.5%) | -$46.00 K(+7.7%) |
Sep 2009 | - | -$42.70 K(+8.4%) |
Jun 2009 | - | -$39.40 K(+11.9%) |
Mar 2009 | - | -$35.20 K(+20.5%) |
Dec 2008 | -$29.20 K | -$29.20 K |
FAQ
- What is Puma Biotechnology annual retained earnings?
- What is the all time high annual retained earnings for Puma Biotechnology?
- What is Puma Biotechnology annual retained earnings year-on-year change?
- What is Puma Biotechnology quarterly retained earnings?
- What is the all time high quarterly retained earnings for Puma Biotechnology?
- What is Puma Biotechnology quarterly retained earnings year-on-year change?
What is Puma Biotechnology annual retained earnings?
The current annual retained earnings of PBYI is -$1.35 B
What is the all time high annual retained earnings for Puma Biotechnology?
Puma Biotechnology all-time high annual retained earnings is -$29.20 K
What is Puma Biotechnology annual retained earnings year-on-year change?
Over the past year, PBYI annual retained earnings has changed by +$21.59 M (+1.58%)
What is Puma Biotechnology quarterly retained earnings?
The current quarterly retained earnings of PBYI is -$1.33 B
What is the all time high quarterly retained earnings for Puma Biotechnology?
Puma Biotechnology all-time high quarterly retained earnings is -$29.20 K
What is Puma Biotechnology quarterly retained earnings year-on-year change?
Over the past year, PBYI quarterly retained earnings has changed by +$23.24 M (+1.71%)